Skip to main navigation Skip to search Skip to main content

Cu2O quantum dots redefining photodynamic therapy with one-minute pathogen inactivation under visible light

Research output: Contribution to journalArticlepeer-review

Abstract

This work utilizes tailored – Cu2O quantum dots (QDs) to demonstrate unprecedented pathogen photo-inactivation. The superior ROS production of the QDs synthesized at 180 °C with a size of 8.10 nm resulted in a 99.98 % reduction of MRSA, 99.78 % of Klebsiella pneumoniae, and 98.92 % of SARS-CoV Delta within 1 min under visible light. Cu2O QDs efficiently reduced 99.25 % viability of 4T1 cancer cells in 15 min while maintaining more than 85 % viability in healthy HEK 293 cells, underlining its selectivity. This finding may establish Cu2O QDs as the next-generation anti-pathogen agents for advanced photodynamic therapy (PDT), biomedical sterilization, and hospital applications.

Original languageEnglish
Article number101248
JournalCase Studies in Chemical and Environmental Engineering
Volume12
DOIs
Publication statusPublished - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CuO QDs
  • Pathogen
  • Photodynamic-therapy
  • Selective-cytotoxicity
  • Ultrafast

Fingerprint

Dive into the research topics of 'Cu2O quantum dots redefining photodynamic therapy with one-minute pathogen inactivation under visible light'. Together they form a unique fingerprint.

Cite this